GLP1R and diabetes mellitus: Initial drug repurposing efforts, or finding new uses for existing medications, have been primarily focused on trials of diabetes treatments such as pioglitazone, glucagon-like peptide 1 receptor (GLP1R) agonists, or sodium-glucose transporter 2 (SGLT2) inhibitors.